Is stem cell therapy for Arterial Hypertension worth it?
Outside a well-designed authorised study, current evidence does not support paying for a cell or exosome product for hypertension. Established risk assessment, adherence, lifestyle measures and medicines have clinically relevant evidence.
How stem cells are studied for Arterial Hypertension
Arterial hypertension is persistently elevated systemic blood pressure with multiple genetic, renal, endocrine, vascular, medicine-related and lifestyle contributors. Cell or exosome research may examine vascular or renal mechanisms, but it has not established a replacement for validated diagnosis, lifestyle measures and antihypertensive medicines.
Am I a candidate? → · Arterial Hypertension: full overview → · Arterial Hypertension cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Arterial Hypertension: cell-therapy evidence and registered trials
- How much does stem cell therapy for Arterial Hypertension cost? (2026)
- Arterial Hypertension stem cell therapy — your questions answered (2026)
- Arterial Hypertension: cell-therapy evidence by therapy class
- MSC vs exosomes for Arterial Hypertension: what the registries show